THE FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH

๐Ÿ‡ฆ๐Ÿ‡บAustralia
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

A Double-blind Randomised, Placebo-controlled Clinical Trial to Test Ambroxol Treatment in ALS

Phase 2
Recruiting
Conditions
Amyotrophic Lateral Sclerosis
Interventions
Drug: Placebo
Drug: Ambroxol
First Posted Date
2023-07-25
Last Posted Date
2023-09-07
Lead Sponsor
The Florey Institute of Neuroscience and Mental Health
Target Recruit Count
50
Registration Number
NCT05959850
Locations
๐Ÿ‡ฆ๐Ÿ‡บ

Concord Repatriation General Hospital, Sydney, New South Wales, Australia

๐Ÿ‡ฆ๐Ÿ‡บ

Launceston General Hospital, Launceston, Tasmania, Australia

๐Ÿ‡ฆ๐Ÿ‡บ

Brain and Mind Centre, Sydney, New South Wales, Australia

and more 2 locations

Suvorexant in the Management Comorbid Sleep Disorder and Alcohol Dependence

First Posted Date
2019-04-01
Last Posted Date
2023-02-15
Lead Sponsor
The Florey Institute of Neuroscience and Mental Health
Target Recruit Count
22
Registration Number
NCT03897062
Locations
๐Ÿ‡ฆ๐Ÿ‡บ

St Vincent's Hospital, Melbourne, Victoria, Australia

Cognition And Neocortical Volume After Stroke

First Posted Date
2014-07-31
Last Posted Date
2022-06-10
Lead Sponsor
The Florey Institute of Neuroscience and Mental Health
Target Recruit Count
175
Registration Number
NCT02205424
Locations
๐Ÿ‡ฆ๐Ÿ‡บ

Austin Health, Heidelberg, Victoria, Australia

๐Ÿ‡ฆ๐Ÿ‡บ

Melbourne Health, Parkville, Victoria, Australia

๐Ÿ‡ฆ๐Ÿ‡บ

Eastern Health, Box Hill, Victoria, Australia

ยฉ Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy